PDD trial design imo as good as it gets. Haven’t heard any complaints about that - but hereby the invitation to try.
From what we know of the P2b/3 trial, the same is true of it. But where the hell is the regulatory site protocol entry...why the delay, is there a possible positive reason, is there a problem or is it simply tardiness?